🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

MD Anderson is proud to have been named by Forbes as one of America's Best Large Employers for 2025. See the list here: brnw.ch/21wQEdj #EndCancer

Thanks to VCCC Alliance & The Picchi Brothers Foundation for supporting my attendance to #KSTCells25 in Vancouver, 🇨🇦 and my visit to Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center in Houston, 🇺🇸. Had an amazing time immersed in incredible research, friendships and new collaborations!

Absolutley stunning work. 😍 Congrats Belkaid Lab & team!!

Our latest study, led by Susan Christo, shows CD47 × PD-L1 bispecific antibodies enhance tumor-resident CD8+ T cell responses, boosting anti-tumor immunity. Grateful to partner with Pfizer Oncology Medical to advance cancer research! 🔬 Doherty Institute onlinelibrary.wiley.com/doi/full/10.10…

Thank you Dr. Pisters - it was an honor to share the progress being made at the Institute for Cell Therapy Discovery & Innovation! Very grateful to Greater Houston Partnership for the opportunity to showcase our efforts to bring transformative cell therapies to patients. Looking forward to

The trailblazing CAR-NK pioneer Katy Rezvani, M.D., Ph.D nk2025.au Discover Tasmania SNI NK Meeting

Please check out our paper published in Nature Medicine on our Phase I trial of AFM13-precomplexed cord blood NK cells in relapsed/refractory CD30+ lymphomas. Led by Dr. Yago Nieto and an outstanding team of coauthors and collaborators, this study marks the first clinical

Well. Another Nerd Nite Melbourne talk done. I’m exhausted. 😴

Amazing & so well deserved!! Congrats Mackay Lab 🙌🥳

Very excited to share our latest research article published with Springer Nature in Nature Communications. We show that in early #MDS, NK cells share mutations with the malignant clones, becoming dysfunctional and failing to eliminate aberrant stem cells. This leads to immune evasion and

A fun collaboration with Dan Kaplan - Check out our latest review on all things skin-immunity out now in Nature Immunology 🔗👇 nature.com/articles/s4159… Pirooz Zareie Doherty Institute

So much of Mackay Lab's advice and philosophy resonates with me: rupress.org/jem/article/22… Journal of Experimental Medicine "be curious, ask questions, and don't be afraid to engage"

Please check out our paper published today in Nature that identifies CREM as a key checkpoint limiting CAR NK cell function.CRISPR knockout of CREM significantly enhanced anti-tumor activity, implicating a broader role in NK cell regulation. Huge congrats to @hindrafei and our

Enhancing anti-tumor immunity of NK cells through targeting IL-15R signaling Nicholas Huntington Iva Nikolic oNKo-innate cell.com/cancer-cell/fu…

Excited to share our Cancer Cell Cell Press article on the discovery of the IL-15 Receptor "Regulome". A technical tour-de-force from the Immunology, computational biology & functional genomics teams oNKo-innate Monash Biomedicine Discovery Institute

Hear from our very own PI herself- Prof. Laura Mackay answers questions about everything career-related and her love for K Drama! 🤩

Thank you Dr Pisters for attending today’s EAB meeting and for your inspiring vision and steadfast support. Deepest thanks also to our extraordinary EAB members: Drs Carl June, Lewis Lanier, Nicholas Huntington Nicholas Huntington , John DiPersio, Helen Heslop, Keith Sullivan,

Congratulations Prof Laura Mackay who has secured a prestigious Cancer Research Institute Institute (USA) grant to advance research into novel immunotherapy targets for breast cancer. The Mackay Lab is leading the way in tissue-resident memory (TRM) cell research and how these cells can

So proud of my brilliant friend. 👇👇

Honoured to be one of this year's Cancer Research Institute Institute's grant recipients. Incredibly grateful for their support of our important research on discovering new immunotherapeutic targets for breast cancer. Doherty Institute